Thrombotic Risk Stratification and Intensive Statin Therapy for Secondary Prevention of Coronary Artery Disease　― Insights From the REAL-CAD Study ―

Abstract

intensity or maximal statin therapy are recommended in very high-risk atherosclerotic cardiovascular disease (ASCVD) patients. 3 Furthermore, a more intensive reduction of lowdensity lipoprotein cholesterol (LDL-C) in patients with ASCVD is recommended in the 2019 European Cardiology H igh-intensity statin therapy has been reported to be associated with significantly lower risk for cardiovascular events in patients with coronary artery disease. 1,2 In the 2018 American College of Cardiology (ACC)/American Heart Association (AHA) guideline, high